NCT02684422View on ClinicalTrials.gov

Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Methicillin-Resistant Staphylococcus AureusCystic Fibrosis
Interventions
OTHER

Intervention N/A. Observational study

There are no interventions to the subjects other than collection of an expectorated sputum since this is an observational study; There are no study groups.See details per detailed study description.

Trial Locations (3)

27599

University of North Carolina at Chapel Hill, Chapel Hill

35233

University of Alabama at Birmingham, Birmingham

98195

University of Washington, Seattle

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT02684422 - Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF) | Biotech Hunter | Biotech Hunter